Target- |
MechanismCell membrane permeability enhancers |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date01 Jul 1998 |
100 Clinical Results associated with ONY Agency LLC
0 Patents (Medical) associated with ONY Agency LLC
100 Deals associated with ONY Agency LLC
100 Translational Medicine associated with ONY Agency LLC